Clinical Trials on Lymphoproliferative Disorders in South Africa

Total 5852 results

Medical University of South Carolina

Completed

Cue Induced Imaging in Nicotine Dependent Smokers

Nicotine Dependence

United States
Medical University of South Carolina
National Alliance for Research on Schizophrenia & Depression

Recruiting

Brief, High-dose rTMS for Depression

Depression | Anxiety

United States
Seagen Inc.

Completed

Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma

Hodgkin Disease

United States
Xingbao Li

Terminated

TMS-fMRI for Neural Pathway in Smokers

Nicotine Dependence

United States
Medical University of South Carolina

Completed

Transcranial Magnetic Stimulation Effects on Nicotine Craving

Nicotine Dependence

United States
Medical University of South Carolina

Completed

Impact of Varenicline on Blood-Oxygen-Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Activation on Smokers (GRAND)

Nicotine Dependence

United States
King's College London

Unknown

A Pilot Trial Of Transdiagnostic Cognitive Behavioural Therapy (tCBT) For Depression And Anxiety In Older People

Depression | Anxiety

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression

Major Depressive Disorder

France, Italy, Russian Federation, South Africa
National Cancer Institute (NCI)

Completed

Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma

Lymphoma

United States
The University of New South Wales
Icahn School of Medicine at Mount Sinai

Unknown

Transcranial Direct Current Stimulation (tDCS) and Cognitive Task in Depression (tDCS + CT)

Depression

Australia
ADC Therapeutics S.A.

Recruiting

A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)

B-Cell Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin Lymphoma

United States, Spain, Italy, United Kingdom, Belgium, Czechia
K-Group Alpha, Inc., a wholly owned subsidiary...

Recruiting

Phase 1 First in Human Study of ZN-d5 as a Single Agent

Acute Myeloid Leukemia | Non Hodgkin Lymphoma

Croatia, Australia, Bulgaria, Korea, Republic of, Ukraine, Poland, Spain
Pfizer

Completed

PF-06741086 Long-term Treatment in Severe Hemophilia

Hemophilia A or B

Poland, Switzerland, South Africa, United States, Croatia, Brazil, Chile
National Institute of Allergy and Infectious Diseases...

Completed

Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma

HIV Infections | Lymphoma, Non-Hodgkin

United States
Human Genome Sciences Inc.

Completed

Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States, Canada, Australia, India
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Completed

Integrated Treatment of OEF/OIF Veterans With PTSD & Substance Use Disorders (COPE)

Alcohol Dependence | Posttraumatic Stress Disorders | Combat Disorders | Drug Dependence

United States
Medical University of South Carolina
Shire

Completed

Evaluating the Methylphenidate Patch to Treat Former Stimulant Users With ADHD

Adult Attention Deficit Hyperactivity Disorder (ADHD)

United States
Hoosier Cancer Research Network
Eli Lilly and Company; Walther Cancer Institute

Terminated

Rituximab and Gemcitabine for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Lymphoma, B-Cell

United States
Medical University of South Carolina

Recruiting

SCORE Emerging Adult Cannabis Use & Stress

Cannabis Use Disorder

United States
Medical University of South Carolina

Completed

N-Acetylcysteine for Youth Cannabis Use Disorder

Cannabis Use Disorder

United States
University of Sydney
Monash University; Sydney Local Health District

Recruiting

MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder (MPATHY)

Alcohol Dependence | PTSD | Alcohol Use Disorder | Post-traumatic Stress Disorder | Comorbidities and Coexisting Conditions

Australia
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Completed

Atomoxetine Treatment for ADHD and Marijuana Dependence

Marijuana Abuse | Attention Deficit Disorder With Hyperactivity

United States
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Completed

Approach Bias Modification for the Treatment of Cannabis Use Disorder

Cannabis Use Disorder

United States
The University of New South Wales
Australian Government Department of Health and Ageing

Completed

Three Year Follow up of a Randomised Controlled Trial (RCT) of an Intervention for Tobacco Dependence Among Those With a Psychotic Illness

Behavior, Addictive | Psychotic Disorder

Australia
The University of New South Wales

Completed

Transcranial Electrical Stimulation (TES) for the Treatment of Depression.

Major Depression

Australia
The University of New South Wales

Completed

Open Pilot Trial of TES for Depression

Major Depression

Australia
The University of New South Wales

Completed

Escitalopram as a Mood Stabilizer for Bipolar II Disorder

Bipolar Disorders

Australia
Sanofi

Completed

Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia

Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Indolent Non-Hodgkin Lymphoma

United States
Medical University of South Carolina

Completed

Acute Aerobic Exercise and Neuroplasticity in Depression

Depressive Disorder | Depression

United States
Vanderbilt University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis

Sarcoidosis; Antimycobacterial Therapy

United States
Medical University of South Carolina
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Impact of Lofexidine on Stress, Craving and Opioid Use

Opioid-use Disorder | Opiate Dependence

United States
Medical University of South Carolina

Completed

Gender Differences in Response to Nicotine Replacement Therapy and De-Nicotinized Cigarettes (BIRCWH)

Nicotine Dependence

United States
Medical University of South Carolina

Completed

Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity

Nicotine Dependence

United States
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Completed

N-Acetylcysteine and Smoking Reduction

Nicotine Dependence

United States
Shire

Completed

Drug Use Study With Intuniv® in Australia

Attention Deficit Hyperactivity Disorder (ADHD)

Australia
Altor BioScience

Terminated

QUILT-3.002: ALT-803 in Patients With Relapse/Refractory iNHL in Conjunction With Rituximab

Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphoma

United States
Biocad

Completed

Safety and Efficacy Study of BCD-020 in Therapy of Indolent Non-Hodgkin's Lymphoma

Splenic Marginal Zone Lymphoma | Nodal Marginal Zone Lymphoma | Follicular Non-Hodgkin's Lymphoma

India, Russian Federation, Colombia, South Africa, Ukraine
VA Office of Research and Development
VA Ann Arbor Healthcare System; Ralph H. Johnson VA Medical Center

Completed

Improving Function Through Primary Care Treatment of PTSD (PE-PC)

Posttraumatic Stress Disorder

United States
University of Sheffield
University of North Carolina, Chapel Hill

Completed

BA Trial for Co-Occurring Depression and Substance Use

Depression | Substance Use Disorders

United Kingdom
Medical University of South Carolina

Completed

Voice Changes During ECT (VAPRE)

Bipolar Depression | Unipolar Depression | Bipolar Disorder, Manic

United States
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Active, not recruiting

Oxytocin to Enhance Alcohol Behavioral Couple Therapy (ABCT)

Alcohol Use Disorder | Couples

United States
Medical University of South Carolina

Completed

Neural Substrates of Emotion: Impact of Cocaine Dependence

Cocaine Use Disorder

United States
Genzyme, a Sanofi Company

Terminated

Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL

Non-Hodgkin's Lymphoma

United States
Millennium Pharmaceuticals, Inc.

Completed

Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma

Multiple Myeloma

United States, Poland, Greece, Australia, Sweden
Hoffmann-La Roche

Completed

A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies

Renal Cell Carcinoma | Chronic Myelogenous Leukemia | Malignant Melanoma

Canada, India, Bulgaria, Russian Federation, Spain, South Africa, Slovakia
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder

Depressive Disorder, Major

Finland, France, South Africa, Estonia, Croatia, Lithuania, Latvia, Slovakia, Poland, Romania
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

Completed

N-acetylcysteine for Tobacco Use Disorder

Smoking | Nicotine Dependence

United States
FBD Biologics Limited

Recruiting

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

Advanced Solid Tumor | Refractory Non-Hodgkin Lymphoma

Taiwan, United States
Delpor, Inc.

Completed

Safety, Tolerability, and Pharmacokinetics of Naltrexone Implant (DLP-160)

Opiod Use Disorder

Australia
Seagen Inc.
Genentech, Inc.

Completed

Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma

Multiple Myeloma

United States

Clinical Trials on Lymphoproliferative Disorders in South Africa

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations